Stuart Alan Weinzimer, MD
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Interim Section Chief, Pediatric Endocrinology & Diabetes
Contact Info
Pediatric Endocrinology & Diabetes
PO Box 208064
New Haven, CT 06520-8064
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Interim Section Chief, Pediatric Endocrinology & Diabetes
Contact Info
Pediatric Endocrinology & Diabetes
PO Box 208064
New Haven, CT 06520-8064
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Interim Section Chief, Pediatric Endocrinology & Diabetes
Contact Info
Pediatric Endocrinology & Diabetes
PO Box 208064
New Haven, CT 06520-8064
United States
About
Titles
Professor
Interim Section Chief, Pediatric Endocrinology & Diabetes
Biography
I earned my bachelor’s degree in molecular biochemistry and biochemistry at Yale University and medical degree at the Albert Einstein College of Medicine. I completed my residency training in pediatrics and fellowship training in pediatric endocrinology at the Children’s Hospital of Philadelphia (CHOP), and joined the faculty in the Department of Pediatrics at the University of Pennsylvania. In 2002 I returned to Yale to focus my research on the continuous glucose sensors and insulin pumps toward the development of an artificial pancreas. I am the Principal Investigator of several NIH- and JDRF- funded artificial pancreas projects. My most recent projects include large-scale clinical trials in automated insulin delivery (artificial pancreas), development of new automated insulin delivery systems specifically designed for young patients, and the studies to characterize the effects of diabetes on the young developing brain. In 2006 I earned Yale’s Mae Gailani Award for Outstanding Clinical Care & Research, and in 2009 I received the Dream Award from the Greater New Haven Chapter of the JDRF. In 2011 I was awarded, along with other principal investigators in the JDRF Continuous Glucose Monitoring Study Group, the Mary Tyler Moore and S. Robert Levine, MD Excellence in Clinical Research Award.
Appointments
Pediatric Endocrinology & Diabetes
ProfessorPrimary
Other Departments & Organizations
- Diabetes Program
- Diabetes Research Center
- Pediatric Endocrinology & Diabetes
- Pediatric Gender Program
- Pediatrics
- WHRY Pilot Project Program Investigators
- Women's Health Research at Yale
- Yale Medicine
- Yale Ventures
Education & Training
- Fellow
- Children's Hospital of Philadelphia (1998)
- Resident
- Children's Hospital of Philadelphia (1995)
- MD
- Albert Einstein College of Medicine (1992)
- BA
- Yale University, Molecular Biochemistry and Biophysics (1988)
Research
Overview
Medical Research Interests
- View Lab Website
Yale Children's Diabetes Program
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
William Tamborlane, MD
Laura Marie Nally, MD
Garrett Ash, PhD
Lisa Fucito, PhD
Michelle Van Name, MD
Sangchoon Jeon, PhD
Diabetes Mellitus, Type 1
Insulin
Insulin Infusion Systems
Pancreas, Artificial
Endocrinology
Publications
2024
Personal and Social‐Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy
Nam S, Jeon S, Ash G, Weinzimer S, Dunton G, Parekh N, Grey M, Chen K, Lee M, Sajdlowska A, Whittemore R. Personal and Social‐Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy. Research In Nursing & Health 2024, 47: 608-619. PMID: 39243147, DOI: 10.1002/nur.22420.Peer-Reviewed Original ResearchConceptsEmotional well-beingType 2 diabetesImprove diabetes outcomesDietary recall dataWell-beingSelf-report toolMultilevel risk factorsEcological momentary assessmentLifestyle behaviorsOnline video callsContinuous glucose monitoringPhysical activityDiabetes outcomesGroup of adultsLifestyle factorsJust-in-time interventionsBaseline surveyDiverse adultsDiabetes InterventionsHigh-risk groupRecall dataMomentary assessmentActigraphy deviceStructural equation modelingGlucose monitoringCost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial.
Fox D, Ware J, Boughton C, Allen J, Wilinska M, Tauschmann M, Denvir L, Thankamony A, Campbell F, Wadwa R, Buckingham B, Davis N, DiMeglio L, Mauras N, Besser R, Ghatak A, Weinzimer S, Kanapka L, Kollman C, Sibayan J, Beck R, Hood K, Hovorka R. Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial. Journal Of Diabetes Science And Technology 2024, 19322968241231950. PMID: 38494876, PMCID: PMC11571777, DOI: 10.1177/19322968241231950.Peer-Reviewed Original ResearchCitationsAltmetricConceptsQuality-adjusted life yearsType 1 diabetesDiabetic ketoacidosisClosed-loop automated insulin deliveryDiscounted quality-adjusted life yearsTreatment groupsContinuous glucose monitoringIncremental cost-effectivenessParallel controlled trialProbabilistic sensitivity analysesInsulin deliveryInsulin pump therapyLifetime cost-effectivenessContemporaneous control groupUsual careImproved HbA<sub>1c</sub>Participants aged 6Health-related quality of lifeAutomated insulin deliverySubgroup patientsTreatment subgroupsSevere hypoglycemiaRandomized trialsTotal health care utilizationLifetime complications
2023
Real-World Diabetes Technology: Overcoming Barriers and Disparities
Messer L, Addala A, Weinzimer S. Real-World Diabetes Technology: Overcoming Barriers and Disparities. Diabetes Technology & Therapeutics 2023, 25: s-176-s-190. PMID: 36802191, DOI: 10.1089/dia.2023.2511.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsPersonalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes
Ash G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, Gulanski B, Spanakis E, Baker J, Weinzimer S, Fucito L. Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes. Clinical Journal Of Sport Medicine 2023, 33: 512-520. PMID: 36715983, PMCID: PMC10898917, DOI: 10.1097/jsm.0000000000001078.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsContinuous glucose monitoringExercise supportHealth informationDigital health informationBody mass indexType 1 diabetesCommunity-based sampleSevere hypoglycemiaMass indexPsychosocial assessmentCGM useHigh satisfaction ratingsPhysician oversightType 1Future interventionsGlucose monitoringMedical readinessMolecular biomarkersBaseline observationsInterventionSatisfaction ratingsAdultsExerciseBehavioral skillsSingle group
2022
Navigating barriers to affording and obtaining insulin and diabetes supplies
Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
Hughes A, Chapman K, Bispham J, Dimsits J, Weinzimer S, Wolf W, Heydarian N. “It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes. Journal Of Clinical & Translational Endocrinology 2022, 30: 100310. PMID: 36620758, PMCID: PMC9816066, DOI: 10.1016/j.jcte.2022.100310.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSevere hypoglycemiaType 1 diabetesGlucagon useMini-dose glucagonEase of administrationPrescription costsNasal administrationEmergency treatmentGlucagon actionPerspectives of adultsHypoglycemiaDiabetesGlucagon treatmentHealthcare professionalsGlucagonAverage durationPerspectives of peopleAdministrationAdultsParticipantsFocus groupsTreatmentCurrent studyFocus group interviewsEmotional impactDKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice
Doyle EA, Weinzimer SA, Tamborlane W. DKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice. The Science Of Diabetes Self-Management And Care 2022, 48: 476-482. PMID: 36129121, DOI: 10.1177/26350106221125699.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsContinuous glucose monitorHigher A1C levelsA1c levelsDKA eventsInsulin pumpPump usersPump-treated patientsRetrospective chart reviewPediatric endocrinology practiceType 1 diabetesInsulin pump usersConcurrent illnessDKA preventionPump patientsDiabetes durationDKA episodesMean A1CChart reviewEndocrinology practiceDKA ratesDKA severityMean ageInsulin omissionMost episodesPatientsConsensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O’Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocrine Reviews 2022, 44: 254-280. PMID: 36066457, PMCID: PMC9985411, DOI: 10.1210/endrev/bnac022.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInsulin delivery technologiesGlycemic goalsNear-normal glucose levelsLong-term complicationsReal-world studyHypoglycemia riskDiabetes QualityConsensus recommendationsGlucose levelsGlobal prevalenceDiabetes managementEligibility criteriaClinical practiceDelivery technologiesHealthcare providersClinical settingDiabetesInsurance coverageSignificant proportionCliniciansAid successPWDPayersComplicationsTremendous advancesAssessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults
Commissariat PV, Volkening LK, Weinzimer SA, Dassau E, Laffel LM. Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults. Canadian Journal Of Diabetes 2022, 47: 66-72. PMID: 36184368, PMCID: PMC10096441, DOI: 10.1016/j.jcjd.2022.08.007.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsYoung adultsTreatment surveyDiabetes device useLess diabetes distressCross-sectional studyType 1 diabetesQuality of lifeImpact of T1DInternal consistencyLower A1CMale sexDiabetes distressExcellent internal consistencyMedical recordsCGM useDiabetes managementT1DHealth outcomesDiabetesType 1Clinical interventionsPsychosocial outcomesBenefit findingA1CAdultsA Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes
Reiss AL, Jo B, Arbelaez AM, Tsalikian E, Buckingham B, Weinzimer SA, Fox LA, Cato A, White NH, Tansey M, Aye T, Tamborlane W, Englert K, Lum J, Mazaika P, Foland-Ross L, Marzelli M, Mauras N. A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes. Nature Communications 2022, 13: 4940. PMID: 36042217, PMCID: PMC9427757, DOI: 10.1038/s41467-022-32289-x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHybrid closed-loop insulin delivery systemStandard care groupType 1 diabetesClosed-loop insulin delivery systemWhite matter volumeCare groupPrimary outcomeInsulin delivery systemsMatter volumeFractional anisotropyCognitive AssessmentRigorous glucose controlDiagnosis of T1DClosed-loop groupBetter diabetes controlDiabetes care groupsConcept pilot studyYears of ageAcademic medical centerFunctional brain activityCortical surface areaMonths study durationRandomized participantsDiabetes controlGlucose control
Clinical Trials
Current Trials
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
HIC ID2000030885RolePrincipal InvestigatorPrimary Completion Date05/31/2023Recruiting ParticipantsGenderBothAge4 years - 17 yearsMechanisms for restoration of hypoglycemia awareness
HIC ID2000023189RoleSub InvestigatorPrimary Completion Date04/30/2023Recruiting ParticipantsImpact of Hypoglycemia on Brain Ketone and Neurotransmitter Metabolism in Type 1 DM
HIC ID1208010648RoleSub InvestigatorPrimary Completion Date09/29/2022Recruiting ParticipantsGenderBothAge18+ yearsPathway to Prevention
HIC ID2000021339RoleSub InvestigatorPrimary Completion Date07/31/2025Recruiting ParticipantsGenderBothAge1 year - 45 years
Academic Achievements & Community Involvement
activity Journal of Diabetes Science and Technology
CommitteesBoard MemberDetailsJournal Serviceactivity International Journal of Pediatric Endocrinology
CommitteesBoard MemberDetailsJournal Serviceactivity American Diabetes Association
CommitteesMemberDetailsADA Professional Practice Committee2010 - Presentactivity Endocrine Society Pediatric Self-Assessment Committee
CommitteesCommittee MemberDetails09/01/2010 - Presentactivity Pediatric Protocol Review Committee
CommitteesMemberDetailsUniversity Service
Clinical Care
Overview
Stuart A. Weinzimer, MD, cares for children with diabetes as well as other endocrine disorders. “During the years of my training in pediatric diabetes, I became aware of the overwhelming burden that diabetes can place on children and their loved ones,” says Dr. Weinzimer. “At the same time, I have witnessed the development of wonderful technologies to ease this burden. I am inspired every day to try to find ways to utilize these technologies to improve the health and outlook of people with diabetes and their loved ones.”
Yale Medicine Pediatrics Diabetes Program is world-renowned for its groundbreaking research in pediatric diabetes and its holistic interdisciplinary approach to care. “My most meaningful accomplishment has been to participate in the development of the artificial pancreas, which promises to transform the lives with people with type 1 diabetes and the people that care for them,” said Dr. Weinzimer, who is a principal investigator in several NIH and JDRF-funded artificial pancreas projects. “My most memorable patient is a young woman I have watched grow from a young toddler with diabetes to a healthy, well-adjusted woman, capable and confident, choosing to help others with diabetes.”
Dr. Weinzimer, a professor of pediatrics (endocrinology) at Yale School of Medicine, also is part of an interdisciplinary team that supports and cares for children and young adults exploring their gender identity.
Clinical Specialties
Fact Sheets
Reproductive Options for Transgender Individuals
Learn More on Yale MedicineHemoglobin A1C Test
Learn More on Yale MedicineType 1 Diabetes: Symptoms, Causes, and Treatments
Learn More on Yale MedicineHyperglycemia: Symptoms, Causes, and Treatments
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
News
- May 02, 2024
56 Yale Pediatricians Recognized by Connecticut Magazine's 2024 “Top Doctors” List
- February 15, 2023
Discoveries & Impact (February 2023)
- September 26, 2022
Ensuring Bone Health for Adolescents Identifying as Transgender
- July 19, 2022
Diabetes Treatment and Research at Yale: 30 Years of Progress
Get In Touch
Contacts
Pediatric Endocrinology & Diabetes
PO Box 208064
New Haven, CT 06520-8064
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.